
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human
Rafeeq Mir, Francesca Tonelli, Paweł Lis, et al.
Biochemical Journal (2018) Vol. 475, Iss. 11, pp. 1861-1883
Open Access | Times Cited: 193
Rafeeq Mir, Francesca Tonelli, Paweł Lis, et al.
Biochemical Journal (2018) Vol. 475, Iss. 11, pp. 1861-1883
Open Access | Times Cited: 193
Showing 1-25 of 193 citing articles:
Inflammation and immune dysfunction in Parkinson disease
Malú G. Tansey, Rebecca L. Wallings, Madelyn C. Houser, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 11, pp. 657-673
Open Access | Times Cited: 781
Malú G. Tansey, Rebecca L. Wallings, Madelyn C. Houser, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 11, pp. 657-673
Open Access | Times Cited: 781
Parkinson disease and the immune system — associations, mechanisms and therapeutics
Eng‐King Tan, Yinxia Chao, Andrew B. West, et al.
Nature Reviews Neurology (2020) Vol. 16, Iss. 6, pp. 303-318
Closed Access | Times Cited: 361
Eng‐King Tan, Yinxia Chao, Andrew B. West, et al.
Nature Reviews Neurology (2020) Vol. 16, Iss. 6, pp. 303-318
Closed Access | Times Cited: 361
Autophagy in Parkinson's Disease
Xu Hou, Jens O. Watzlawik, Fabienne C. Fiesel, et al.
Journal of Molecular Biology (2020) Vol. 432, Iss. 8, pp. 2651-2672
Open Access | Times Cited: 280
Xu Hou, Jens O. Watzlawik, Fabienne C. Fiesel, et al.
Journal of Molecular Biology (2020) Vol. 432, Iss. 8, pp. 2651-2672
Open Access | Times Cited: 280
Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson’s Disease
Maria Nguyen, Yvette C. Wong, Daniel Ysselstein, et al.
Trends in Neurosciences (2018) Vol. 42, Iss. 2, pp. 140-149
Open Access | Times Cited: 270
Maria Nguyen, Yvette C. Wong, Daniel Ysselstein, et al.
Trends in Neurosciences (2018) Vol. 42, Iss. 2, pp. 140-149
Open Access | Times Cited: 270
α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies
Michael X. Henderson, John Q. Trojanowski, Virginia M.‐Y. Lee
Neuroscience Letters (2019) Vol. 709, pp. 134316-134316
Open Access | Times Cited: 225
Michael X. Henderson, John Q. Trojanowski, Virginia M.‐Y. Lee
Neuroscience Letters (2019) Vol. 709, pp. 134316-134316
Open Access | Times Cited: 225
Recent advancements in polyethyleneimine-based materials and their biomedical, biotechnology, and biomaterial applications
Zhonghui Chen, Ziyu Lv, Yi‐Feng Sun, et al.
Journal of Materials Chemistry B (2020) Vol. 8, Iss. 15, pp. 2951-2973
Closed Access | Times Cited: 177
Zhonghui Chen, Ziyu Lv, Yi‐Feng Sun, et al.
Journal of Materials Chemistry B (2020) Vol. 8, Iss. 15, pp. 2951-2973
Closed Access | Times Cited: 177
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease
Danna Jennings, Sarah Huntwork‐Rodriguez, Anastasia G. Henry, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 648
Closed Access | Times Cited: 161
Danna Jennings, Sarah Huntwork‐Rodriguez, Anastasia G. Henry, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 648
Closed Access | Times Cited: 161
Increased LRRK2 kinase activity alters neuronal autophagy by disrupting the axonal transport of autophagosomes
C. Alexander Boecker, Juliet Goldsmith, Dan Dou, et al.
Current Biology (2021) Vol. 31, Iss. 10, pp. 2140-2154.e6
Open Access | Times Cited: 135
C. Alexander Boecker, Juliet Goldsmith, Dan Dou, et al.
Current Biology (2021) Vol. 31, Iss. 10, pp. 2140-2154.e6
Open Access | Times Cited: 135
The cell biology of Parkinson’s disease
Nikhil Panicker, Preston Ge, Valina L. Dawson, et al.
The Journal of Cell Biology (2021) Vol. 220, Iss. 4
Open Access | Times Cited: 110
Nikhil Panicker, Preston Ge, Valina L. Dawson, et al.
The Journal of Cell Biology (2021) Vol. 220, Iss. 4
Open Access | Times Cited: 110
LRRK2 and idiopathic Parkinson’s disease
Emily M. Rocha, Matthew T. Keeney, Roberto Di Maio, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 3, pp. 224-236
Open Access | Times Cited: 105
Emily M. Rocha, Matthew T. Keeney, Roberto Di Maio, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 3, pp. 224-236
Open Access | Times Cited: 105
Mitochondrial Dysfunction in Parkinson’s Disease: From Mechanistic Insights to Therapy
Xiaoyan Gao, Tuo Yang, Ying Gu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 74
Xiaoyan Gao, Tuo Yang, Ying Gu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 74
Danna Jennings, Sarah Huntwork‐Rodriguez, Maurits F. J. M. Vissers, et al.
Movement Disorders (2023) Vol. 38, Iss. 3, pp. 386-398
Open Access | Times Cited: 45
Key genes and convergent pathogenic mechanisms in Parkinson disease
Robert Coukos, Dimitri Krainc
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 6, pp. 393-413
Closed Access | Times Cited: 26
Robert Coukos, Dimitri Krainc
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 6, pp. 393-413
Closed Access | Times Cited: 26
Cell biology of Parkinson's disease: Mechanisms of synaptic, lysosomal, and mitochondrial dysfunction
Sarah M. Brooker, G Naylor, Dimitri Krainc
Current Opinion in Neurobiology (2024) Vol. 85, pp. 102841-102841
Closed Access | Times Cited: 24
Sarah M. Brooker, G Naylor, Dimitri Krainc
Current Opinion in Neurobiology (2024) Vol. 85, pp. 102841-102841
Closed Access | Times Cited: 24
Leucine-Rich Repeat Kinases
Dario R. Alessi, Suzanne R. Pfeffer
Annual Review of Biochemistry (2024) Vol. 93, Iss. 1, pp. 261-287
Closed Access | Times Cited: 17
Dario R. Alessi, Suzanne R. Pfeffer
Annual Review of Biochemistry (2024) Vol. 93, Iss. 1, pp. 261-287
Closed Access | Times Cited: 17
Glial phagocytic clearance in Parkinson’s disease
Marie‐Ève Tremblay, Mark Cookson, Laura Civiero
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 124
Marie‐Ève Tremblay, Mark Cookson, Laura Civiero
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 124
Role of the endolysosomal system in Parkinson’s disease
D. J. Vidyadhara, John E. Lee, Sreeganga S. Chandra
Journal of Neurochemistry (2019) Vol. 150, Iss. 5, pp. 487-506
Open Access | Times Cited: 124
D. J. Vidyadhara, John E. Lee, Sreeganga S. Chandra
Journal of Neurochemistry (2019) Vol. 150, Iss. 5, pp. 487-506
Open Access | Times Cited: 124
Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease
Matthew Taylor, Dario R. Alessi
Current Opinion in Cell Biology (2020) Vol. 63, pp. 102-113
Open Access | Times Cited: 116
Matthew Taylor, Dario R. Alessi
Current Opinion in Cell Biology (2020) Vol. 63, pp. 102-113
Open Access | Times Cited: 116
PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins
Kerryn Berndsen, Paweł Lis, Wondwossen M Yeshaw, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 114
Kerryn Berndsen, Paweł Lis, Wondwossen M Yeshaw, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 114
Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics
Konstantin Senkevich, Ziv Gan‐Or
Parkinsonism & Related Disorders (2019) Vol. 73, pp. 60-71
Open Access | Times Cited: 109
Konstantin Senkevich, Ziv Gan‐Or
Parkinsonism & Related Disorders (2019) Vol. 73, pp. 60-71
Open Access | Times Cited: 109
The effect of LRRK2 loss-of-function variants in humans
Nicola Whiffin, Irina M. Armean, Aaron Kleinman, et al.
Nature Medicine (2020) Vol. 26, Iss. 6, pp. 869-877
Open Access | Times Cited: 97
Nicola Whiffin, Irina M. Armean, Aaron Kleinman, et al.
Nature Medicine (2020) Vol. 26, Iss. 6, pp. 869-877
Open Access | Times Cited: 97
Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration
Xi Chen, Jennifer K. Kordich, Erin T. Williams, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 12, pp. 5765-5774
Open Access | Times Cited: 96
Xi Chen, Jennifer K. Kordich, Erin T. Williams, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 12, pp. 5765-5774
Open Access | Times Cited: 96
Dynamic control of the dopamine transporter in neurotransmission and homeostasis
Mengfei Bu, Matthew J. Farrer, Habibeh Khoshbouei
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 92
Mengfei Bu, Matthew J. Farrer, Habibeh Khoshbouei
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 92
Coatopathies: Genetic Disorders of Protein Coats
Esteban C. Dell’Angelica, Juan S. Bonifacino
Annual Review of Cell and Developmental Biology (2019) Vol. 35, Iss. 1, pp. 131-168
Open Access | Times Cited: 88
Esteban C. Dell’Angelica, Juan S. Bonifacino
Annual Review of Cell and Developmental Biology (2019) Vol. 35, Iss. 1, pp. 131-168
Open Access | Times Cited: 88
Lrrk2 alleles modulate inflammation during microbial infection of mice in a sex-dependent manner
Bojan Shutinoski, Mansoureh Hakimi, Irene E. Harmsen, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 511
Closed Access | Times Cited: 83
Bojan Shutinoski, Mansoureh Hakimi, Irene E. Harmsen, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 511
Closed Access | Times Cited: 83